| Fatima Mozaffar, PHARMD | |
|
12691 Antioch Rd, Overland Park, KS 66213-1701 | |
| (913) 681-9665 | |
| Not Available |
| Full Name | Fatima Mozaffar |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 12691 Antioch Rd, Overland Park, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912681081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-107245 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Fatima Mozaffar, PHARMD 8513 W 145th Ter, Overland Park, KS 66223-1361 Ph: (913) 940-0722 | Fatima Mozaffar, PHARMD 12691 Antioch Rd, Overland Park, KS 66213-1701 Ph: (913) 681-9665 |
News Archive
Researchers at Shanghai Public Health Clinical Center have made important discoveries about the immune response among patients who have recovered from mild COVID-19 disease that could help to inform prevention and treatment methods, as well as improve the efficacy of community testing.
The Honourable Rona Ambrose, Minister of Health, today announced that the Government of Canada will donate doses of an experimental Ebola vaccine developed by the Public Health Agency of Canada to the World Health Organization (WHO) in its role as an international coordinating body in responding to the ongoing Ebola outbreak in West Africa.
Research, advocacy and education must "close the gaps" in cardiovascular health disparities among races, an American Heart Association writing group reports in today's special disparities issue of Circulation: Journal of the American Heart Association.
VIVUS, Inc. today announced that additional data on Qnexa(TM), an investigational drug candidate for obesity, was presented at the 27th annual scientific meeting of The Obesity Society (TOS) in Washington D.C. Wesley W. Day, PhD, vice president of clinical development at VIVUS, presented the additional data from the company's two year-long phase 3 obesity trials during the Pharmacotherapy Update portion of the pre-conference on October 24, 2009.
When it comes to risk disclosures made by drug companies in print and television ads, many consumers are not paying attention, according to a recent study by ORC Guideline (an infoGROUP company). The latest study in the company's Under the Skin series found that 41% of US consumers pay little or no attention to risk information presented by pharmaceutical companies in their TV commercials, and only half (50%) pay attention to such disclosures in print ads. This lack of attention is most prevalent among those 55 years of age or older.
› Verified 5 days ago
Jennifer Ortolani, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9000 Metcalf Ave, Overland Park, KS 66212 Phone: 613-649-4314 Fax: 913-649-4483 | |
Monique Hsu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7000 W 75th St, Overland Park, KS 66204 Phone: 913-432-3396 | |
Elisabeth Gossman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9501 Nall Ave, Overland Park, KS 66207 Phone: 913-648-1210 | |
Barbara C Loehr, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8901 W 75th St, Overland Park, KS 66204 Phone: 913-789-3976 | |
Dr. Barbara Hilmes Bodanske, RPH PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13811 Woodward St, Overland Park, KS 66223 Phone: 913-681-5425 | |
Katelyn Steele, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7000 W 75th St, Overland Park, KS 66204 Phone: 913-432-3396 | |
Dr. Michael Porterfield, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 12290 College Blvd, Overland Park, KS 66210 Phone: 913-327-1332 Fax: 913-327-7533 |